CompletedN/AMDMA

Role of Serotonin in Acute and Subacute MDMA Effects

Sponsored by California Pacific Medical Center Research Institute

NCT ID
NCT00838305
Target Enrollment
13 participants
Start Date
2009-02
Est. Completion
2011-08

About This Study

The purpose of this study is to measure the effects of MDMA (particularly its emotional effects) and to determine the role of serotonin in these effects. Serotonin is a neurotransmitter, which is a chemical that is released by some brain cells to communicate with other brain cells. Many of the effects of MDMA are thought to be the result of increased serotonin release. In order to understand the effects of MDMA and role of serotonin in these effects, we will administer MDMA alone and in combination with the antidepressant citalopram (one trade name for this is Celexa). Citalopram decreases the ability of MDMA to release serotonin. Citalopram will therefore decrease any of MDMA's effects that are the result of serotonin release; we want to measure this.

Conditions Studied

MDMA Mechanism of Action

Interventions

  • MDMA and citalopram
  • Placebo

Eligibility

Age:18 Years - 50 Years
Healthy Volunteers:Yes
View full eligibility criteria
Inclusion Criteria:

* Healthy men or women aged 18 to 50 years
* Experienced with MDMA

Exclusion Criteria:

* Significant physical or psychiatric illness which might impair the ability to safely complete the study or that might be complicated by the study drugs, including prior seizures (after age 8), history of major depression, or other active neurological disease or clinically significant abnormalities on physical examination or screening laboratory values

Study Locations (1)

CPMC Research Institute, St.Luke's Hospital
San Francisco, California, United States

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source

Role of Serotonin in Acute and Subacute MDMA Effects | Huxley